IRAK1BP1 and neoplasm: Further investigation of IRAK1BP1 expression in publicly available LUAD patient data found that IRAK1BP1 expression was lower in tumor samples relative to the corresponding normal tissue; and its predictive power is independent from other known indicators of patient outcome, such as known oncogenic mutations, tumor mutation burden, age or gender.